HomeBUSINESS
BUSINESS

PI Starts in US for Daiichi Sankyo/Sanford Burnham’s TNAP Inhibitor
(Sep.8.2017)

Daiichi Sankyo and Sanford Burnham Prebys Medical Discovery Institute said that they have initiated a PI clinical study in the US for DS-1211, the first-in-class tissue non-specific alkaline phosphatase (TNAP) inhibitor jointly developed by the two partners ...
(LOG IN FOR FULL STORY)

News Calendar